Apellis Pharmaceuticals (APLS)
(Delayed Data from NSDQ)
$49.93 USD
+1.21 (2.48%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $49.85 -0.08 (-0.16%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: BMO |
3/2024 | $-0.55 | -29.19% |
Earnings Summary
For their last quarter, Apellis Pharmaceuticals (APLS) reported earnings of -$0.73 per share, missing the Zacks Consensus Estimate of -$0.66 per share. This reflects a negative earnings surprise of 10.61%. Look out for APLS's next earnings release on May 07, 2024. For the next earning release, we expect the company to report earnings of -$0.55 per share, reflecting a year-over-year increase of 64.74%.
Earnings History
Price & Consensus
Zacks News for APLS
Apellis (APLS) Q4 Earnings Miss, Revenues Meet Estimates
APLS: What are Zacks experts saying now?
Zacks Private Portfolio Services